Development and Validation of a Simple and Sensitive Reverse-Phase High Performance Liquid Chromatographic Method for the Determination of Ibuprofen in Pharmaceutical Suspensions

被引:1
作者
Elias, Kenan G. [1 ]
Hilal, Yumen [2 ]
机构
[1] Al Baath Univ, Fac Pharm, Dept Pharmaceut Chem & Drug Qual Control, Homs, Syria
[2] Al Baath Univ, Fac Pharm, Dept Pharmaceut Analyt & Food Chem, Homs, Syria
关键词
Developed; Ibuprofen; Method validation; RP-HPLC; Suspension;
D O I
10.21123/bsj.2022.6860
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The aim of this work was to develop and validate a rapid and low cost method for estimation of ibuprofen in pharmaceutical suspensions using Reverse-Phase High Performance Liquid Chromatography. The proposed method was conducted and validated according to International Conference on Harmonization (ICH) requirements. The chromatographic parameters were as follows: column of octyldecylsilyl C18 with dimensions (150 x 4.6) mm, mobile phase composed of acetonitrile with phosphoric acid with a ratio of 50 to 50 each using isocratic mode, flow rate of 1.5 mL/min and injection volume of 5 mu L. The detection was carried out using UV detector at 220 nm. The method was validated and showed short retention time for ibuprofen peak at 7.651 min, with linearity in the studied range of 0.4 -1.6 mg/mL (R2 = 0.9999) and with great accuracy [percent recovery was (100.48%), percent relative error(-1.511-1.465)%] and repeatability (RSD% = 0.112 for Retention time). The detection and quantitation limits were determined to be 0.036 and 0.110 mg/mL, respectively. This method was applied successfully to determine the content of ibuprofen in three commercial pharmaceutical products. Looking at the short time of analysis and the low limit detection, we recommend this method for routine assays in the quality control laboratories and as a good method for stability studies of ibuprofen.
引用
收藏
页码:550 / 559
页数:10
相关论文
共 23 条
  • [1] Abdalraheem A., 2020, J CHEM-NY, V2020, P1
  • [2] Alsirawan M.B., 2013, INT J PHARM PHARM SC, V5, P227
  • [3] [Anonymous], 2005, VAL AN PROC TEXT MET, P17
  • [4] [Anonymous], 2016, US PHARMACOPEIAL CON, P1640
  • [5] RP-HPLC Method Development and Validation of Synthesized Codrug in Combination with Indomethacin, Paracetamol, and Famotidine
    Assali, Mohyeddin
    Abualhasan, Murad
    Zohud, Nihal
    Ghazal, Noura
    [J]. INTERNATIONAL JOURNAL OF ANALYTICAL CHEMISTRY, 2020, 2020
  • [6] Development and Validation of a Stability-Indicating HPLC Method for the Simultaneous Determination of Florfenicol and Flunixin Meglumine Combination in an Injectable Solution
    Batrawi, Nidal
    Naseef, Hani
    Al-Rimawi, Fuad
    [J]. JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY, 2017, 2017
  • [7] Buckingham R, 2020, MARTINDALE COMPLETE, V40th, P7
  • [8] Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
    Catella-Lawson, F
    Reilly, MP
    Kapoor, SC
    Cucchiara, AJ
    DeMarco, S
    Tournier, B
    Vyas, SN
    FitzGerald, GA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) : 1809 - 1817
  • [9] de la Guardia M, 2020, RSC GREEN CHEM SER, V66, P1
  • [10] Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs for patients with primary dysmenorrhea: A network meta-analysis
    Feng, Xuan
    Wang, Xiaoyun
    [J]. MOLECULAR PAIN, 2018, 14